Tag U.S.

The U.S. Healthcare Reform: Impact on the Pharmaceutical Industry

Jul29

Research and Markets has announced the addition of Decision Resources, Inc.’s new report "U.S. Healthcare Reform: Impact on the Pharmaceutical Industry" to their offering (see also Biologics).Healthcare reform is coming to the United States and everyone is asking, Whats in it for me? The debate to pass healthcare reform into law was long and contentious, [...]

Xoft Announces Exclusive Contract With Premier for Electronic Brachytherapy

Jul29

Premier Inc., an alliance of more than 2,300 U.S. hospitals and 67,000-plus other healthcare sites working together to achieve high quality, cost-effective care, and Xoft, Inc., the leading provider of FDA-cleared Electronic Brachytherapy Systems, announced the execution of a group purchasing contract. Xoft was awarded an exclusive three-year contract for brachytherapy systems with Premier Purchasing [...]

New Online Rx System Makes UM Student ‘Top Entrepreneur’ Finalist

Jul29

COLLEGE PARK, Md., July 30 The University of Maryland issued the following news release:A student-run company that helps doctors submit prescriptions online, as new federal regulations will eventually require, has made a University of Maryland senior a finalist for Entrepreneur Magazine’s Entrepreneur of 2010 Awards.Greg Waldstreicher, a student in the Hinman CEOs Program – [...]

Baxter Announces Final Details Regarding Previously Communicated COLLEAGUE Infusion Pump Recall in the U.S.

Jul29

Baxter International Inc. announced that the U.S. Food and Drug Administration (FDA) has issued its final order regarding the previously communicated recall of COLLEAGUE infusion pumps from the U.S. market. Baxter will offer replacement infusion pumps or refunds to owners of COLLEAGUE pumps and will execute the recall over the next two years to minimize [...]

Hospira to test generic anemia drug: Health care reform prompts interest in ‘biosimilar’ biotech drugs [Chicago Tribune]

Jul28

July 29In the wake of health reform’s passage into law, Hospira Inc. will begin testing a cheaper version of a popular anemia biotech treatment in the first phase of a U.S. clinical trial.Lake Forest-based Hospira said it will begin the first phase of trials for a "biosimilar," or a biogeneric, version of brand-name Epogen in [...]

Shionogi Inc. Announces FDA Approval of CUVPOSA? for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions

Jul28

FLORHAM PARK, N.J., July 29 /PRNewswire/ Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA? (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA? was designated [...]

Boston Scientific Announces FDA Approval of New Leads for the Precision Plus? Spinal Cord Stimulator System

Jul28

NATICK, Mass., July 29 /PRNewswire-FirstCall/ Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus? Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear? [...]

Stock Marketing Inc Presents!! VKNG,GHLV,APNT,AEGY,NUBL,CEMI:: Sign Up With Us Today!!

Jul28

STOCK MARKETING INC PRESENTS : (OTCBB: VKNG) Viking Systems, Inc., (OTCBB: GHLV) Global Health Ventures, Inc., (OTCBB: APNT) Applied Nanotech Holdings, Inc., (OTCBB: AEGY) Alternative Energy Partners Inc., (OTCBB: NUBL) Numobile, Inc., (OTCBB: CEMI) Chembio Diagnostics, Incwww.StockMarketingInc.comFor More Information email us!! Steve@StockMarketingInc.com
(OTCBB: VKNG – Viking Systems, Inc.)LATEST NEWS!!Viking Systems and Boston Scientific Extend Supply ContractWESTBOROUGH, [...]

WORLDWIDE HEALTHCARE TRUST PLC

Jul28

Finsbury Worldwide Pharmaceutical Trust PLC Annual Financial Report for the year ended 31 March 2010 A copy of the Company’s Annual Financial Report can be found on the Company’s [...]

Endologix Receives FDA Approval for PowerFit Aortic Extensions

Jul28

IRVINE, Calif., July 29 /PRNewswire-FirstCall/ Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that it has received U.S. Food and Drug Administration (FDA) approval for its new PowerFit? Aortic Extensions. The PowerFit extensions are designed to provide physicians with enhanced visibility under fluoroscopy to facilitate precise device placement [...]

Your Ad Here